Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study.
Almanza-Aguilera E, Martínez-Huélamo M, López-Hernández Y, Guiñón-Fort D, Guadall A, Cruz M, Perez-Cornago A, Rostgaard-Hansen AL, Tjønneland A, Dahm CC, Katzke V, Schulze MB, Masala G, Agnoli C, Tumino R, Ricceri F, Lasheras C, Crous-Bou M, Sánchez MJ, Aizpurua-Atxega A, Guevara M, Tsilidis KK, Chatziioannou AC, Weiderpass E, Travis RC, Wishart DS, Andrés-Lacueva C, Zamora-Ros R.
Almanza-Aguilera E, et al. Among authors: cruz m.
Cancers (Basel). 2024 Dec 8;16(23):4116. doi: 10.3390/cancers16234116.
Cancers (Basel). 2024.
PMID: 39682302
Free PMC article.